Senior insider sale
EVP, Strategy & Innovation at XENON PHARMACEUTICALS INC. — senior position signals high conviction
$2.30M
60K shares
What this filing means
ROBIN SHERRINGTON plans to sell 60K shares of XENON PHARMACEUTICALS INC. valued at approximately $2.30M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/12/2024ACC: 0000950170-24-072572
Officer· EVP, Strategy & Innovation
Since Sep 2019
60K
Shares to sell
$2.30M
Approx. market value
73.50K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months4
Equity Incentive Grant
See remarks
10/23/2017
11KEquity Incentive Grant
See remarks
3/13/2017
27.50KEquity Incentive Grant
See remarks
3/11/2016
20KEquity Incentive Grant
See remarks
12/18/2015
15KTotal acquired73.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/23/2017 | Equity Incentive Grant See remarks | 11K | — |
3/13/2017 | Equity Incentive Grant See remarks | 27.50K | — |
3/11/2016 | Equity Incentive Grant See remarks | 20K | — |
12/18/2015 | Equity Incentive Grant See remarks | 15K | — |
| Total | 73.50K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
60K
Market value
$2.30M
6/12/2024
Total
Units
60K
Value
$2.30M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/12/2024 | 60K | $2.30M | NASDAQ | Planned |
| Total | 60K | $2.30M | ||